Analysts count on sales decrease GlaxoSmithKline, relatively high dividend

Tomorrow the English GlaxoSmithKline will report its past quarter's results. For this year GlaxoSmithKline 's revenue will be around 29,85 billion GBp. This is according to the average of the analysts' estimates. This is slightly lower than 2016's revenue of 30,19 billion GBp.

Historical revenues and results GlaxoSmithKline plus estimates 2018

The analysts expect for 2018 a net profit of 5,21 billion GBp. The majority of the analysts expects for this year a profit per share of 107 GBp. So the price/earnings-ratio equals 13,5.

Huge dividend GlaxoSmithKline

Per share the analysts are expecting a dividend of 80 GBp per share. The dividend yield is then 5,54 percent. The average dividend yield of the pharmaceutical companies equals a moderate 1 percent.

Most recent target prices around 1595 GBp

The most recent recommendations for the pharmaceutical company are from Sanford C. Bernstein & Co, Exane BNP Paribas and ABN AMRO.

GlaxoSmithKline 's market value equals around 7095,11 billion .

At 10.52 the stock trades 0,68 percent higher at 1445 GBp.

Historical stock prices GlaxoSmithKline

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.